BSX vs STEM · P/E 20, rev $16.75B vs rev $144.6M
Boston Scientific Corp (BSX) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. STEM currently screens at market cap $82.1M.
Not investment advice. Open the BSX and STEM stock pages for the full models.
Not investment advice.